Moderna
MRNA
#275
Rank
NZ$157.15 B
Marketcap
NZ$393.64
Share price
-0.47%
Change (1 day)
703.69%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

ESG Reports

Thumbnail Moderna
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report
Thumbnail Moderna
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report